BTG plc Announced FDA Approval Of VISTOGARD (Uridine Triacetate) As Antidote To Overdose And Early Onset, Severe, Or Life-Threatening Toxicities From Chemotherapy Drugs 5-Fluorouracil (5-FU) Or Capecitabine
BTG plc Announced FDA Approval Of VISTOGARD (Uridine Triacetate) As Antidote To Overdose And Early Onset, Severe, Or Life-Threatening Toxicities From Chemotherapy Drugs 5-Fluorouracil (5-FU) Or Capecitabine